Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1364503

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibrodysplasia Ossificans Progressiva: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what specialist care and treatments are currently available through the NHS for people suffering from fibrodysplasia ossificans progressiva.
tabling member printed	Lord Caine
uin	HL3513
answer	answer is ministerial correction date of answer 11/11/2021 answer text <p>There is no specific prescribed service for treatment of fibrodysplasia ossificans progressiva (FOP). However, children with FOP are cared for by National Health Service paediatric rheumatologists and/or geneticists with input from other clinicians as required.</p><p>New medicines and treatments for ultra-rare diseases such as FOP are considered via highly specialised technology (HST) evaluations by the National Institute for Health and Care Excellence (NICE). NICE is currently developing HST guidance on palovarotene for preventing heterotopic ossification associated with FOP.</p><p>The UK Rare Diseases Framework, published in 2021, outlined four key priorities to improve the lives of those living with rare diseases, such as FOP, including improving access to specialist care, treatment and drugs. Action plans to improve access to care and treatment will be published by each of the four United Kingdom nations within two years. A copy of the Framework is attached.</p> answering member printed Lord Kamall grouped question UIN HL3514 question first answered 11/11/2021 13:34:39 answering member 4909 label Biography information for Lord Kamall attachment 1 file name The UK Rare Diseases Framework.pdf title The UK Rare Diseases Framework
tabling member	4581 label Biography information for Lord Caine

1364504

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibrodysplasia Ossificans Progressiva: Health Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have, if any, to expand the provision of specialist NHS care and treatment for people suffering from fibrodysplasia ossificans progressiva.
tabling member printed	Lord Caine
uin	HL3514
answer	answer is ministerial correction date of answer 11/11/2021 answer text <p>There is no specific prescribed service for treatment of fibrodysplasia ossificans progressiva (FOP). However, children with FOP are cared for by National Health Service paediatric rheumatologists and/or geneticists with input from other clinicians as required.</p><p>New medicines and treatments for ultra-rare diseases such as FOP are considered via highly specialised technology (HST) evaluations by the National Institute for Health and Care Excellence (NICE). NICE is currently developing HST guidance on palovarotene for preventing heterotopic ossification associated with FOP.</p><p>The UK Rare Diseases Framework, published in 2021, outlined four key priorities to improve the lives of those living with rare diseases, such as FOP, including improving access to specialist care, treatment and drugs. Action plans to improve access to care and treatment will be published by each of the four United Kingdom nations within two years. A copy of the Framework is attached.</p> answering member printed Lord Kamall grouped question UIN HL3513 question first answered 11/11/2021 13:34:39 answering member 4909 label Biography information for Lord Kamall attachment 1 file name The UK Rare Diseases Framework.pdf title The UK Rare Diseases Framework
tabling member	4581 label Biography information for Lord Caine

1364505

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibrodysplasia Ossificans Progressiva: Research
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have, if any, to increase research funding in order to find more effective treatments and a cure for fibrodysplasia ossificans progressiva.
tabling member printed	Lord Caine
uin	HL3515
answer	answer is ministerial correction date of answer 11/11/2021 answer text <p>The Department funds research into rare diseases such as fibrodysplasia ossificans progressiva (FOP) via the National Institute for Health Research (NIHR). In the past five years, the Department has provided funding to support eight studies into FOP through the NIHR. Within the NIHR, for all disease areas, the amount of funding depends on the volume and quality of scientific activity and the usual practice is not to ring-fence funds for particular topics.</p><p>The UK Rare Diseases Framework, published in January 2021, outlined a vision for improving the lives of those with rare diseases, such as FOP, including a focus on pioneering research. Action plans setting out further details on this research will be published by each of the four United Kingdom nations within two years. A copy of the Framework is attached.</p> answering member printed Lord Kamall question first answered 11/11/2021 13:33:43 answering member 4909 label Biography information for Lord Kamall attachment 1 file name The UK Rare Diseases Framework.pdf title The UK Rare Diseases Framework
tabling member	4581 label Biography information for Lord Caine

1364506

registered interest
date	28/10/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Fibrodysplasia Ossificans Progressiva: Carers
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what support they are giving to families who are caring for family members  suffering from fibrodysplasia ossificans progressiva.
tabling member printed	Lord Caine
uin	HL3516
answer	answer is ministerial correction date of answer 11/11/2021 answer text <p>For patients with rare diseases such as fibrodysplasia ossificans progressiva, expert centres provide clinical guidance, support and advice to patients, their families and carers. The NHS Long Term Plan set out ambitions to improve the identification and support of unpaid carers. These ambitions include providing timely information and support for contingency planning; developing more integrated support systems within primary care; support for young carers; and work to ensure that carers from frequently excluded communities are engaged and enabled to use services.</p> answering member printed Lord Kamall question first answered 11/11/2021 16:21:20 answering member 4909 label Biography information for Lord Kamall
tabling member	4581 label Biography information for Lord Caine